Tefron Ltd.
TFRFF
$6.43
-$0.03-0.46%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -17.36% | -19.26% | -15.87% | -3.40% | 5.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -17.36% | -19.26% | -15.87% | -3.40% | 5.02% |
| Cost of Revenue | -15.15% | -17.04% | -13.34% | -2.42% | 5.83% |
| Gross Profit | -25.12% | -26.87% | -24.35% | -6.69% | 2.26% |
| SG&A Expenses | -3.10% | -8.29% | -4.22% | 5.91% | 11.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -37.87% | -37.87% | -4.34% | -4.34% | -4.34% |
| Total Operating Expenses | -12.94% | -15.43% | -11.75% | -1.10% | 6.75% |
| Operating Income | -77.56% | -64.13% | -60.45% | -28.04% | -13.99% |
| Income Before Tax | -95.44% | -74.33% | -66.85% | -27.38% | -11.19% |
| Income Tax Expenses | -66.27% | -47.54% | -66.56% | -42.93% | -28.56% |
| Earnings from Continuing Operations | -102.86% | -82.21% | -66.94% | -22.60% | -5.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -102.86% | -82.21% | -66.94% | -22.60% | -5.35% |
| EBIT | -77.56% | -64.13% | -60.45% | -28.04% | -13.99% |
| EBITDA | -57.13% | -50.97% | -48.76% | -22.09% | -8.45% |
| EPS Basic | -102.42% | -82.02% | -67.07% | -23.07% | -7.92% |
| Normalized Basic EPS | -94.71% | -74.03% | -66.97% | -27.77% | -13.51% |
| EPS Diluted | -103.66% | -82.59% | -66.83% | -23.48% | -9.25% |
| Normalized Diluted EPS | -95.34% | -74.06% | -66.25% | -27.82% | -14.34% |
| Average Basic Shares Outstanding | 0.34% | -1.34% | 1.11% | 0.98% | 2.63% |
| Average Diluted Shares Outstanding | -4.39% | -4.08% | -3.38% | -0.03% | 2.55% |
| Dividend Per Share | -- | -- | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -37.11% | 4.81% | 2.12% | 0.33% | -- |